|
|
||||||||
Journal of Lipid Research, Vol 30, 443-449, Copyright © 1989 by Lipid Research, Inc.
SG Young and ST Hubl
An apolipoprotein (apo) B-specific monoclonal antibody, MB19, detects a
commonly occurring two-allele genetic polymorphism in human apoB (Young, S.
G., S. J. Bertics, L. K. Curtiss, D. C. Casal, and J. L. Witztum. 1986.
Proc. Natl. Acad. Sci. USA. 83: 1101-1105). Antibody MB19 binds to two
different allotypes of apoB, MB19(1) and MB19(2), with high and low
affinity, respectively. The epitope for antibody MB19 is located within
apoB-100 thrombolytic fragment T4 (apoB-100 amino acid residues 1-1297). In
this study, we examined the relationship of the MB19 polymorphism to a
C----T nucleotide substitution at apoB cDNA nucleotide 421. This nucleotide
substitution results in a Thr----Ile substitution at apoB-100 amino acid
71, and it changes an ApaLI restriction endonuclease site in the apoB gene.
The nucleotide substitution was easily detectable by ApaLI digestion of a
141-base pair fragment of the apoB gene obtained by enzymatic amplification
of genomic DNA. In 62 subjects, the MB19 phenotype, as determined by
radioimmunoassays, correlated perfectly with the ApaLI restriction site
polymorphism in the amplified DNA. The apoB allotype MB19(1) is associated
with an Ile at residue 71 and the absence of the ApaLI site, whereas the
apoB allotype MB19(2) is associated with a Thr at residue 71 and the
presence of the ApaLI site. We conclude that the amino acid substitution at
residue 71 probably accounts for the MB19 polymorphism in apoB.
ARTICLES
An ApaLI restriction site polymorphism is associated with the MB19 polymorphism in apolipoprotein B
Gladstone Foundation Laboratories for Cardiovascular Disease, University of California, San Francisco 94140-0608.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Flood, M. Gustafsson, P. E. Richardson, S. C. Harvey, J. P. Segrest, and J. Boren Identification of the Proteoglycan Binding Site in Apolipoprotein B48 J. Biol. Chem., August 23, 2002; 277(35): 32228 - 32233. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cheng, M. A. Grow, C. Pallaud, W. Klitz, H. A. Erlich, S. Visvikis, J. J. Chen, C. R. Pullinger, M. J. Malloy, G. Siest, et al. A Multilocus Genotyping Assay for Candidate Markers of Cardiovascular Disease Risk Genome Res., October 1, 1999; 9(10): 936 - 949. [Abstract] [Full Text] |
||||
![]() |
C. R. Pullinger, D. Gaffney, M. M. Gutierrez, M. J. Malloy, V. N. Schumaker, C. J. Packard, and J. P. Kane The apolipoprotein B R3531C mutation: characteristics of 24 subjects from 9 kindreds J. Lipid Res., February 1, 1999; 40(2): 318 - 327. [Abstract] [Full Text] |
||||
![]() |
K. Tran, J. Boren, J. Macri, Y. Wang, R. McLeod, R. K. Avramoglu, K. Adeli, and Z. Yao Functional Analysis of Disulfide Linkages Clustered within the Amino Terminus of Human Apolipoprotein B J. Biol. Chem., March 27, 1998; 273(13): 7244 - 7251. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ilmonen, T. Helio, R. Butler, A. Palotie, P. Pietinen, J. K. Huttunen, and M. J. Tikkanen Two New Immunogenetic Polymorphisms of the ApoB Gene and Their Effect on Serum Lipid Levels and Responses to Changes in Dietary Fat Intake Arterioscler. Thromb. Vasc. Biol., September 1, 1995; 15(9): 1287 - 1293. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |